REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

CELEBER-PHARMA Kft. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: CELEBER-PHARMA Kft. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

CELEBER-PHARMA Kft. is based in Hungary. The head office is in Pecs. It operates in the Pharmacies and Drug Stores industry. It was first established on March 14, 2008. CELEBER-PHARMA Kft. currently employs 12 (2023) people. There was a net sales revenue increase of 15.66% reported in CELEBER-PHARMA Kft.’s latest financial highlights for 2024. Its total assets grew by 6.28% over the same period. The net profit margin of CELEBER-PHARMA Kft. increased by 2.7% in 2024.

Headquarters
Kocsag utca 25.
Pecs; Baranya; Postal Code: 7634

Contact Details: Purchase the CELEBER-PHARMA Kft. report to view the information.

Basic Information
Total Employees:
Purchase the CELEBER-PHARMA Kft. report to view the information.
Registered Capital:
Purchase the CELEBER-PHARMA Kft. report to view the information.
Financial Auditors:
Purchase the CELEBER-PHARMA Kft. report to view the information.
Incorporation Date:
March 14, 2008
Key Executives
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Oboler-Med Kft
Company Performance
Financial values in the chart are available after CELEBER-PHARMA Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
15.66%▲
Total operating revenue
18.7%▲
Operating profit (EBIT)
58.73%▲
EBITDA
54.51%▲
Net Profit (Loss) for the Period
59.45%▲
Total Assets
6.28%▲
Total Equity
24.49%▲
Operating Profit Margin (ROS)
2.94%▲
Net Profit Margin
2.7%▲
Return on Equity (ROE)
11.36%▲
Quick Ratio
0.47%▲
Cash Ratio
0.43%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo